We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $96.1B
1-Year Est. Return 40.06%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$48.6B
AUM Growth
+$1.55B
Cap. Flow
-$1.45B
Cap. Flow %
-2.99%
Top 10 Hldgs %
16.48%
Holding
2,644
New
42
Increased
557
Reduced
1,045
Closed
62

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$284M
2
HON icon
Honeywell
HON
+$171M
3
EA
Electronic Arts
EA
+$165M
4
MO icon
Altria Group
MO
+$162M
5
GWW icon
W.W. Grainger
GWW
+$156M

Top Sells

Rank Stock Value
1
LLL
L3 Technologies, Inc.
LLL
+$276M
2
ZTS icon
Zoetis
ZTS
+$211M
3
APH icon
Amphenol
APH
+$169M
4
AVGO icon
Broadcom
AVGO
+$163M
5
PEP icon
PepsiCo
PEP
+$162M

Sector Composition

Rank Sector Weight
1 Technology 20.49%
2 Healthcare 14.06%
3 Industrials 12.94%
4 Consumer Discretionary 12.93%
5 Financials 12.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGYS icon
2376
Agilysys
AGYS
$3.01B
$177K ﹤0.01%
10,865
CALX icon
2377
Calix
CALX
$2.49B
$177K ﹤0.01%
21,826
INO icon
2378
Inovio Pharmaceuticals
INO
$79.1M
$177K ﹤0.01%
2,660
SGYP
2379
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$177K ﹤0.01%
104,372
LL
2380
DELISTED
LL Flooring Holdings, Inc.
LL
$174K ﹤0.01%
11,259
SPWR
2381
DELISTED
SunPower Corporation Common Stock
SPWR
$173K ﹤0.01%
36,133
LCI
2382
DELISTED
Lannett Company, Inc.
LCI
$173K ﹤0.01%
9,095
+2,757
+43% +$105K
OXFD
2383
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$172K ﹤0.01%
10,572
COLL icon
2384
Collegium Pharmaceutical
COLL
$843M
$171K ﹤0.01%
11,635
NERV icon
2385
Minerva Neurosciences
NERV
$206M
$171K ﹤0.01%
1,698
GLRE icon
2386
Greenlight Captial
GLRE
$503M
$170K ﹤0.01%
13,694
CLBK icon
2387
Columbia Financial
CLBK
$1.15B
$169K ﹤0.01%
10,122
KEYW
2388
DELISTED
The KEYW Holding Corporation
KEYW
$169K ﹤0.01%
19,478
PHH
2389
DELISTED
PHH Corporation
PHH
$169K ﹤0.01%
15,420
PDLI
2390
DELISTED
PDL BioPharma, Inc.
PDLI
$169K ﹤0.01%
64,117
BFIN
2391
DELISTED
BankFinancial
BFIN
$168K ﹤0.01%
10,569
INWK
2392
DELISTED
InnerWorkings, Inc.
INWK
$168K ﹤0.01%
21,206
-2,521
-11% -$19.8K
ABEO icon
2393
Abeona Therapeutics
ABEO
$422M
$166K ﹤0.01%
519
REVG
2394
DELISTED
REV Group
REVG
$166K ﹤0.01%
10,550
ACRS icon
2395
Aclaris Therapeutics
ACRS
$871M
$165K ﹤0.01%
11,341
CRBP icon
2396
Corbus Pharmaceuticals
CRBP
$184M
$165K ﹤0.01%
728
SD icon
2397
SandRidge Energy
SD
$531M
$164K ﹤0.01%
15,097
BRS
2398
DELISTED
Bristow Group, Inc.
BRS
$163K ﹤0.01%
13,444
ENPH icon
2399
Enphase Energy
ENPH
$5.59B
$162K ﹤0.01%
33,377
ZIXI
2400
DELISTED
Zix Corporation
ZIXI
$162K ﹤0.01%
29,128

Similar funds

VOYA Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, VOYA Investment Management held 2,644 positions worth $48.6B, up 3.3% from $47B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 3.9%. VOYA Investment Management opened 42 new positions and exited 62, leaving the 2,644-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

  • VOYA Investment Management's largest Q3 2018 buy was Vanguard Global ex-US Real Estate ETF: 1,294,352 shares worth $72.7M.
  • VOYA Investment Management added most to Biogen in Q3 2018, an estimated $284M increase.
  • VOYA Investment Management's biggest Q3 2018 reduction was L3 Technologies, Inc., cutting an estimated $276M.
  • VOYA Investment Management fully exited State Street SPDR Bloomberg High Yield Bond ETF in Q3 2018, selling an estimated $59M.
  • VOYA Investment Management's ten largest holdings make up 16% of its $48.6B portfolio in Q3 2018.
  • VOYA Investment Management opened 42 new positions and closed 62 in Q3 2018.
  • VOYA Investment Management's portfolio value rose 3.3% quarter-over-quarter to $48.6B.

Based on VOYA Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.